Name
Rapid Infection Diagnostics Inc.
Company Description
RID leverages advanced mass spectrometry to enable a suite of rapid diagnostic tests that reduce microbiology testing times from days to hours. Our technology is designed specifically for the needs of large diagnostics labs.
Our platform provides rapid identification (ID) and antibiotic susceptibility testing (AST) data for microbes. The RID platform currently supports two assays: UTIDx (urine) and BSIDx (blood).
Product Categories (10)
Infectious Disease Testing, Metabolomics, Microbiology, Product Development/Services
Included In the Export Interest Directory
Yes
Business Needs
Investor, Licensing Agreements
Countries of Interest
Canada, United States
Address
2500 University Dr NW
Calgary, AB T2N 2A3
Canada
LinkedIn